GRADED A+
NURS 6531: Advanced Practice Care of Adults - Midterm Examination | Core Domains: Advanced
Health Assessment & Diagnostic Reasoning for Adults, Pathophysiology & Management of Common
Acute & Chronic Conditions, Pharmacology & Prescriptive Authority, Health Promotion & Disease
Prevention, Geriatric Considerations & Aging Physiology, Diagnostic Test Interpretation & Selection,
and Evidence-Based Clinical Decision Making | Adult-Gerontology Primary Care Nurse Practitioner
Focus | Comprehensive Midterm Exam Format
Exam Structure
The NURS 6531 Midterm Exam for the 2026/2027 academic cycle is a 120-question, multiple-choice
question (MCQ) examination.
Introduction
This NURS 6531 Midterm Exam guide for the 2026/2027 cycle prepares AGPCNP students for the
comprehensive mid-program assessment of adult-focused advanced practice content. The content
integrates advanced assessment techniques, complex pathophysiology, pharmacologic management, and
diagnostic reasoning required for providing evidence-based, patient-centered care to adult and older adult
populations in primary care settings.
Answer Format
All correct answers and clinical management strategies must be presented in bold and green, followed
by detailed rationales that apply adult/geriatric-specific assessment techniques, justify differential
diagnoses based on clinical presentation, select appropriate pharmacologic therapies, and incorporate
current clinical guidelines (e.g., USPSTF, ADA, ACC/AHA) into care plans.
Questions (120 Total)
1. A 68-year-old male presents with progressive dyspnea on exertion, orthopnea, and bilateral lower
extremity edema. BNP is 450 pg/mL. What is the most likely diagnosis?
A. COPD exacerbation
B. Heart failure with reduced ejection fraction (HFrEF)
C. Pulmonary embolism
D. Pneumonia
Rationale: Symptoms of volume overload (orthopnea, edema) and elevated BNP (>100 pg/mL)
strongly suggest heart failure. HFrEF is confirmed by echo showing EF <40%. While COPD can cause
dyspnea, it typically lacks orthopnea and edema. PE presents with pleuritic pain and hypoxia;
pneumonia with fever and consolidation.
,2. According to the 2023 ACC/AHA guidelines, what is the target blood pressure for a 72-year-old with
hypertension and type 2 diabetes?
A. <140/90 mm Hg
B. <130/80 mm Hg
C. <150/90 mm Hg
D. <120/70 mm Hg
Rationale: ACC/AHA 2023 recommends BP <130/80 mm Hg for adults with diabetes or high
cardiovascular risk, including older adults who are otherwise healthy. For frail elderly or those with
multiple comorbidities, individualization is key, but standard goal remains <130/80.
3. A 55-year-old female reports fatigue, weight gain, and cold intolerance. TSH is 12.5 mIU/L (normal
0.4–4.0), free T4 is low. What is the first-line treatment?
A. Levothyroxine 25 mcg daily
B. Levothyroxine 1.6 mcg/kg/day based on ideal body weight
C. Liothyronine (T3)
D. Observation
Rationale: This is primary hypothyroidism. Standard initial dose is 1.6 mcg/kg/day of ideal body
weight. For a 70 kg woman, this is ~112 mcg/day. Starting low (25–50 mcg) is reserved for elderly or
cardiac patients. T3 monotherapy is not recommended. Treatment should begin promptly.
4. Which screening test is recommended annually for colorectal cancer in average-risk adults aged
45–75?
A. Colonoscopy
B. Fecal immunochemical test (FIT)
C. CT colonography every year
D. Serum CEA
Rationale: USPSTF 2023 recommends annual high-sensitivity FIT as one option for colorectal cancer
screening. Colonoscopy is every 10 years; CT colonography every 5 years. CEA is a tumor marker, not a
screening tool.
5. A 78-year-old male with atrial fibrillation has a CHA₂DS₂-VASc score of 4. What is the appropriate
anticoagulation strategy?
,A. Aspirin 81 mg daily
B. Direct oral anticoagulant (e.g., apixaban)
C. No anticoagulation needed
D. Clopidogrel
Rationale: CHA₂DS₂-VASc ≥2 in men warrants anticoagulation. DOACs (apixaban, rivaroxaban) are
preferred over warfarin due to fewer interactions and no routine monitoring. Aspirin is ineffective for
stroke prevention in AFib and increases bleeding risk when combined with anticoagulants.
6. A 62-year-old female presents with sudden right-sided facial droop, slurred speech, and left arm
weakness. What is the priority diagnostic test?
A. CT abdomen
B. Non-contrast CT head
C. Lumbar puncture
D. EEG
Rationale: This presentation suggests acute ischemic stroke. A non-contrast CT head is performed
immediately to rule out hemorrhage before considering thrombolytics (e.g., tPA within 4.5 hours). MRI
is more sensitive but takes longer. LP and EEG are not first-line for stroke evaluation.
7. A 70-year-old male with CKD stage 3 (eGFR 42 mL/min) requires pain management after knee
replacement. Which medication is safest?
A. Naproxen
B. Acetaminophen
C. Ibuprofen
D. Celecoxib
Rationale: NSAIDs (naproxen, ibuprofen, celecoxib) can worsen renal function and cause fluid
retention in CKD. Acetaminophen is the preferred analgesic in mild-moderate pain for patients with
kidney disease. Opioids may be used cautiously if needed, but acetaminophen is first-line.
8. A 50-year-old male with no cardiac history has an LDL of 190 mg/dL. What is the next step per
ACC/AHA guidelines?
A. Lifestyle modification only
, B. High-intensity statin therapy
C. Ezetimibe alone
D. Repeat lipid panel in 6 months
Rationale: ACC/AHA identifies four statin benefit groups. One is LDL ≥190 mg/dL (severe
hypercholesterolemia), which warrants high-intensity statin (e.g., atorvastatin 40–80 mg) regardless
of other risk factors. Lifestyle changes are adjunctive, not sufficient alone.
9. An 80-year-old female presents with new-onset confusion, urinary incontinence, and falls. What
condition should be suspected?
A. Alzheimer’s dementia
B. Urinary tract infection (UTI)
C. Depression
D. Normal pressure hydrocephalus
Rationale: In older adults, UTI often presents atypically with delirium, falls, or incontinence—not
dysuria or frequency. Delirium is acute and fluctuating; dementia is chronic. Always rule out infection
in new cognitive/functional decline in geriatric patients.
10. A 65-year-old male with type 2 diabetes has an HbA1c of 9.2% on metformin 1000 mg BID. What is
the next best step per ADA 2026 standards?
A. Add insulin glargine
B. Add a GLP-1 receptor agonist (e.g., semaglutide)
C. Switch to sulfonylurea
D. Increase metformin to maximum dose
Rationale: ADA 2026 recommends adding a GLP-1 RA as second-line therapy for patients with
ASCVD, CKD, or obesity—even if HbA1c is not at goal. GLP-1 RAs provide glycemic control, weight loss,
and cardiovascular/kidney protection. Metformin is already at max dose (2000 mg/day).
11. An older adult taking 10 medications is at highest risk for:
A. Improved cognition
B. Adverse drug reactions and nonadherence